Skip to Content

PROGRAF CONCENTRATE FOR INFUSION 5MG/ML

Active substance(s): TACROLIMUS

View full screen / Print PDF » Download PDF ⇩
Transcript
Package leaflet: Information for the user
Prograf® 5 mg/ml concentrate for solution for infusion

146947 GBprogLFT

Prograf AMP 5/1

Tacrolimus

Great Britain

Read all of this leaflet carefully before you start using this medicine because it contains
important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor, pharmacist or nurse.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm
them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any
possible side effects not listed in this leaflet. See section 4.

148x610mm
LFT_215 FD

23.06.15/15:28

VTB 5573

Eq. to: N/A

What is in this leaflet
1. What Prograf® is and what it is used for
2. What you need to know before you use Prograf®
3. How to use Prograf®
4. Possible side effects
5. How to store Prograf®
6. Contents of the pack and other information
1. What Prograf® is and what it is used for

black

Prograf belongs to a group of medicines called immunosuppressants. Following your organ
transplant (e.g. liver, kidney, heart), your body’s immune system will try to reject the new organ.
Prograf® is used to control your body’s immune response enabling your body to accept the
transplanted organ.
Prograf® is often used in combination with other medicines that also suppress the immune
system.
®

You may also be given Prograf® for an ongoing rejection of your transplanted liver, kidney, heart
or other organ or if any previous treatment you were taking was unable to control this immune
response after your transplantation.
2. What you need to know before you use Prograf®
Do not use Prograf®
- If you are allergic (hypersensitive) to tacrolimus or to any antibiotic belonging to the
subgroup of macrolide antibiotics (e.g. erythromycin, clarithromycin, josamycin).
- If you are allergic (hypersensitive) to any of the other ingredients of Prograf® (listed in
section 6) - in particular polyoxyethylene hydrogenated castor oil or similar substances.

146947 GBprogLFT

Warnings and precautions
Talk to your doctor, pharmacist or nurse before taking Prograf®
- Whilst you are receiving Prograf® your doctor may want to carry out a number of tests
(including blood, urine, heart function, visual and neurological tests) from time to time. This
is quite normal and will help your doctor to decide on the most appropriate dose of Prograf®
for you.
- Please avoid taking any herbal remedies, e.g. St. John’s wort (Hypericum perforatum) or
any other herbal products as this may affect the effectiveness and the dose of Prograf® that
you need to receive. If in doubt please consult your doctor prior to taking any herbal products
or remedies.
- If you have liver problems or have had a disease which may have affected your liver, please
tell your doctor as this may affect the dose of Prograf® that you receive.
- If you feel strong abdominal pain accompanied or not with other symptoms, such as chills,
fever, nausea or vomiting.
- If you have diarrhoea for more than one day, please tell your
doctor, because it might be necessary to adapt the dose of
Prograf® that you receive.
- If you have an alteration of the electrical activity of your heart
called “QT prolongation”.
- 
Limit your exposure to sunlight and UV light whilst taking
Prograf® by wearing appropriate protective clothing and using
a sunscreen with a high sun protection factor. This is because of
the potential risk of malignant skin changes with
immunosuppressive therapy.
- If you need to have any vaccinations, please inform your doctor beforehand. Your doctor will
advise you on the best course of action.
- Patients treated with Prograf® have been reported to have an increased risk of developing
lymphoproliferative disorders (see section 4). Ask your doctor for specific advice on these
disorders.
Other medicines and Prograf®
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines, including medicines obtained without a prescription and herbal remedies.
Prograf® must not be used with ciclosporin.
Prograf® blood levels can be affected by other medicines you take, and blood levels of other
medicines can be affected by using Prograf® which may require interruption, an increase or
a decrease in Prograf® dose. In particular, you should tell your doctor if you are taking or have
recently taken medicines with active substances like:
- antifungal medicines and antibiotics (particularly so-called macrolide antibiotics) used to
treat infections e.g. ketoconazole, fluconazole, itraconazole, voriconazole, clotrimazole,
erythromycin, clarithromycin, josamycin, and rifampicin
- HIV protease inhibitors (e.g. ritonavir, nelfinavir, saquinavir), used to treat HIV infection
- HCV protease inhibitors (e.g. telaprevir, boceprevir), used to treat hepatitis C infection
- medicines for stomach ulcer and acid reflux (e.g. omeprazole, lansoprazole or cimetidine)
- antiemetics, used to treat nausea and vomiting (e.g. metoclopramide)
- magnesium-aluminium-hydroxide (antacid), used to treat heartburn
- hormone treatments with ethinylestradiol (e.g. the oral contraceptive pill) or danazol
- medicines for high blood pressure or heart problems such as nifedipine, nicardipine,
diltiazem and verapamil
- anti-arrhythmic medicines (amiodarone) used to control arrhythmia (uneven beating of the
heart)
- medicines known as “statins” used to treat elevated cholesterol and triglycerides
- the anti-epileptic medicines phenytoin or phenobarbital
- the corticosteroids prednisolone and methylprednisolone
- the anti-depressant nefazodone
- herbal preparations containing St. John's Wort (Hypericum perforatum) or extracts of
Schisandra sphenanthera.
Tell your doctor if you are taking or need to take ibuprofen, amphotericin B, or antivirals (e.g.
aciclovir). These may worsen kidney or nervous system problems when taken together with
Prograf®.
Your doctor also needs to know if you are taking potassium supplements or potassium-sparing
diuretics (e.g., amiloride, triamterene, or spironolactone), certain pain killers (so-called NSAIDs,
e.g. ibuprofen), anticoagulants, or oral medication for diabetic treatment, while you receive
Prograf®.
If you need to have any vaccinations, please inform your doctor beforehand.
Prograf® with food and drink
Grapefruit and grapefruit juice should be avoided while using Prograf®.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby,
ask your doctor or pharmacist for advice before taking this medicine. Prograf® is excreted into
breast milk. Therefore you should not breast-feed whilst receiving Prograf®.
Prograf® contains polyoxyethylene hydrogenated castor oil and ethanol
- Prograf® contains polyoxyethylene hydrogenated castor oil that may, in a small number of
patients, lead to a severe allergic reaction. If you have previously had such a problem,
please inform your doctor.
- Prograf® contains 81 vol % ethanol (alcohol), i.e. up to 638 mg per dose, equivalent to 16 ml
beer, 7 ml wine per dose. Harmful for those suffering from alcoholism. To be taken into
account in pregnant or breast-feeding women, children and high-risk groups such as
patients with liver disease or epilepsy.
3. How to take Prograf®
The starting dose to prevent the rejection of your transplanted organ will be determined by your
doctor calculated according to your body weight. Initial intravenous doses just after
transplantation will generally be in the range of
0.01 – 0.10 mg per kg body weight per day
depending on the transplanted organ.
Prograf® should be used for intravenous infusion only after it is diluted. You will receive Prograf®
as a continuous 24-hour infusion and never as a short injection.
Prograf® may cause mild irritation if it is not infused directly into a vein.
Treatment with Prograf® should not continue for more than 7 days. Your doctor will then prescribe
Prograf® capsules for you instead.
Your dose depends on your general condition and on which other immunosuppressive
medication you are taking. Regular blood tests by your doctor will be required to define the
correct dose and to adjust the dose from time to time.
If you receive more Prograf® than you should
If you have received too much Prograf®, your doctor will amend your next dose.
If you stop using Prograf®
Stopping your treatment with Prograf® may increase the risk of rejection of your transplanted
organ. Do not stop your treatment unless your doctor tells you to do so.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, Prograf® can cause side effects, although not everybody gets them.
Prograf® reduces your body’s own defence mechanism to stop you rejecting your transplanted
organ. Consequently, your body will not be as good as usual at fighting infections. So if you are
taking Prograf® you may therefore catch more infections than usual such as infections of the
skin, mouth, stomach and intestines, lungs and urinary tract.
Severe side effects may occur, including the ones listed below. Tell your doctor immediately if
you have or suspect you may have any of the following serious side effects:
- Opportunistic infections (bacterial, fungal, viral and protozoal): prolonged diarrhea, fever
and sore throat.
- Benign and malignant tumours have been reported following treatment as a result of
immunosuppression.
- Thrombotic Thrombocytopenic Purpura (or TTP) a condition characterised by fever and
bruising under the skin that may appear as red pinpoint dots, with or without unexplained
extreme tiredness, confusion, yellowing of the skin or eyes (jaundice), with symptoms of
acute renal failure (low or no urine output).
- Cases of pure red cell aplasia (a very severe reduction in red blood cell counts) and

146947 GBprogLFT.indd 1

23-06-15 15:28

haemolytic anaemia (decreased number of red blood cells due to abnormal breakdown
accompanied with tiredness) have been reported. You may have no symptoms or depending
on the severity of the condition, you may feel: fatigue, apathy, abnormal paleness of the skin
(pallor), shortness of breath, dizziness, headache, chest pain and coldness in hands and
feet.
- Cases of agranulocytosis (a severely lowered number of white blood cells accompanied
with ulcers in the mouth, fever and infection(s)). You may have no symptoms or you may feel
sudden fever, rigors and sore throat.
- Allergic and anaphylactic reactions with the following symptoms: a sudden itchy rash
(hives), swelling of hands, feet, ankle, face, lips, mouth or throat (which may cause difficulty
in swallowing or breathing) and you may feel you are going to faint.
- Posterior Reversible Encephalopathy Syndrome (PRES): headache, altered mental status,
seizures, and visual disturbances.
- Torsades de Pointes: change in the heart frequency that can be accompanied or not by
symptoms, such as chest pain (angina), faint, vertigo or nausea, palpitations (feeling the
heartbeat) and difficulty breathing.
- Gastrointestinal perforation: strong abdominal pain accompanied or not with other
symptoms, such as chills, fever, nausea or vomiting.
- Stevens-Johnson syndrome: unexplained widespread skin pain, facial swelling, serious
illness with blistering of skin, mouth, eyes and genitals, hives, tongue swelling, red or purple
skin rash that spreads, skin shedding.
- Toxic epidermal necrolysis: erosion and blistering of skin or mucous membranes, red
swollen skin that can detach in large parts of the body.
- Haemolytic uraemic syndrome, a condition with the following symptoms: low or no urine
output (acute renal failure), extreme tiredness, yellowing of the skin or eyes (jaudince) and
abnormal bruising or bleeding and signs of infection.
- Insufficient function of your transplanted organ
The side effects listed below may also occur after receiving Prograf®:
Very common side effects (may affect more than 1 in 10 people):
- Increased blood sugar, diabetes mellitus, increased potassium in the blood
- Difficulty in sleeping
- Trembling, headache
- Increased blood pressure
- Diarrhoea, nausea
- Kidney problems
Common side effects (may affect up to 1 in 10 people):
- Reduced magnesium, phosphate, potassium, calcium or sodium in the blood, fluid
overload, increased uric acid or lipids in the blood, decreased appetite, increased acidity of
the blood, other changes in the blood salts
- Anxiety symptoms, confusion and disorientation, depression, mood changes, nightmare,
hallucination, mental disorders
- Fits, disturbances in consciousness, tingling and numbness (sometimes painful) in the
hands and feet, dizziness, impaired writing ability, nervous system disorders
- Blurred vision, increased sensitivity to light, eye disorders
- Ringing sound in your ears
- Reduced blood flow in the heart vessels, faster heartbeat
- Bleeding, partial or complete blocking of blood vessels, reduced blood pressure
- Shortness in breath, changes in the lung tissue, collection of liquid around the lung,
inflammation of the pharynx, cough, flu-like symptoms
- Inflammations or ulcers causing abdominal pain or diarrhoea, bleeds in the stomach,
inflammations or ulcers in the mouth, collection of fluid in the belly, vomiting, abdominal
pains, indigestion, constipation, flatulence, bloating, loose stools, stomach problems
- Changes in liver enzymes and function, yellowing of the skin due to liver problems, liver
tissue damage and inflammation of the liver
- Itching, rash, hair loss, acne, increased sweating
- Pain in joints, limbs or back, muscle spasms
- Insufficient function of the kidneys, reduced production of urine, impaired or painful urination
- General weakness, fever, collection of fluid in your body, pain and discomfort, increase of
the enzyme alkaline phosphatase in your blood, weight gain, feeling of temperature
disturbed
Uncommon side effects (may affect up to 1 in 100 people):
- Changes in blood clotting, reduction in all blood cell counts
- Dehydration, reduced protein or sugar in the blood, increased phosphate in the blood
- Coma, bleeding in the brain, stroke, paralysis, brain disorder, speech and language
abnormalities, memory problems
- Blurring of the vision due to abnormality in the lens of the eye
- Impaired hearing
- Irregular heartbeat, stop of heartbeat, reduced performance of your heart, disorder of the
heart muscle, enlargement of the heart muscle, stronger heartbeat, abnormal ECG, heart
rate and pulse abnormal
- Blood clot in a vein of a limb, shock
- Difficulties in breathing, respiratory tract disorders, asthma
- Obstruction of the gut, increased blood level of the enzyme amylase, reflux of stomach
content in your throat, delayed emptying of the stomach
- Dermatitis, burning sensation in the sunlight
- Joint disorders
- Inability to urinate, painful menstruation and abnormal menstrual bleeding
- Failure of some organs, influenza like illness, increased sensitivity to heat and cold, feeling
of pressure on your chest, jittery or abnormal feeling, increase of the enzyme lactate
dehydrogenase in your blood, weight loss
Rare side effects (may affect up to 1 in 1,000 people):
- Small bleeds in your skin due to blood clots
- Increased muscle stiffness
- Blindness
- Deafness
- Collection of fluid around the heart
- Acute breathlessness
- Cyst formation in your pancreas
- Problems with blood flow in the liver
- Increased hairiness
- Thirst, fall, feeling of tightness in your chest, decreased mobility, ulcer
Very rare side effects (may affect up to 1 in 10,000 people):
- Muscular weakness
- Echocardiogram abnormal
- Liver failure, narrowing of the bile vessel
- Painful urination with blood in the urine
- Increase of fat tissue
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not
listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information
on the safety of this medicine.
5. How to store Prograf®
Keep out of the sight and reach of children.
Do not use Prograf® after the expiry date which is stated on the carton and ampoule after EXP.
The expiry date refers to the last day of that month.
Store ampoule in the original package in order to protect from light.
Do not store above 25 °C.
6. Contents of the pack and other information
What Prograf® contains
-
-

The active substance is tacrolimus. 1 ml of concentrate for solution for infusion contains
5 mg of tacrolimus.
The other ingredients are polyoxyethylene hydrogenated castor oil and dehydrated alcohol.

What Prograf® looks like and contents of the pack
The concentrate is a clear colourless solution supplied in transparent glass ampoules. Each
ampoule contains 1 ml of concentrate for solution for infusion, which must be diluted before use.
Each carton contains 10 ampoules.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Astellas Pharma Ltd.
2000 Hillswood Drive
Chertsey
Surrey
KT16 0RS
UK.
Manufacturer:
Astellas Ireland Co. Ltd.
Killorglin
County Kerry
Ireland
This medicinal product is authorised in the Member States of the EEA under the
following names:
Prograf®:
Austria, Cyprus, Czech Republic, Denmark, Germany, Greece, Spain, Finland, France,
Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Slovakia, Slovenia, Sweden, United
Kingdom.
Prograft®:
Belgium, Luxembourg, The Netherlands
This leaflet was last revised in 06/2015.
--------------------------------------------------------------------------------------------------------------------------The following information is intended for medical or healthcare professionals only:
Prograf® 5 mg/ml concentrate for solution for infusion must not be injected undiluted.
Prograf® 5 mg/ml concentrate for solution for infusion should be diluted in 5 % w/v glucose
solution or physiological saline solution in polyethylene, polypropylene or glass bottles, but not
in PVC containers. Only transparent and colourless solutions should be used.
The concentration of a solution for infusion should be within the range 0.004 - 0.100 mg/ml.
The total volume of infusion during a 24-hour period should be in the range 20 – 500 ml.
The diluted solution should not be given as a bolus.
The solution for infusion should be used within 24 hours.
Unused concentrate for infusion in an opened ampoule or unused reconstituted solution should
be disposed of immediately to avoid contamination.

146947 GBprogLFT

146947 GBprogLFT.indd 2

23-06-15 15:28

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide